Literature DB >> 2797002

Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding.

A Migliaccio1, M Di Domenico, S Green, A de Falco, E L Kajtaniak, F Blasi, P Chambon, F Auricchio.   

Abstract

Hormone binding controls the activity of estradiol receptor. The in vitro synthesized human receptor binds hormone with high affinity and low efficiency (1-4% of the maximal binding). We now report that phosphorylation on tyrosine of the synthetic receptor by an extensively purified calf uterus kinase increases hormone binding towards maximal levels without change in affinity. This is the first direct demonstration that a newly synthesized hormone receptor acquires ligand binding through phosphorylation. The use of in vitro synthesized proteins as substrates for enzymes which cause functional modifications of proteins is very promising because it is easy to identify the modified domains and residues by using deleted and point mutated proteins. Experiments with two estradiol receptor deletion mutants, one which lacks the N-terminal half of the receptor and binds hormone independently from the N-terminal half of the receptor, the other which lacks the C-terminal half of the receptor and contains the domain required to recognize the estradiol responsive elements, show that tyrosine phosphorylation occurs exclusively within or near the hormone binding domain of the receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797002     DOI: 10.1210/mend-3-7-1061

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  16 in total

1.  International Conference on Growth Control in Breast Cancer: Basic and Clinical Aspects. Taormina, Italy, December 13-14, 1991. Abstracts.

Authors: 
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Effects of flutamide on [methyl-(3)h]-choline uptake in human prostate cancer-3 cells: a pilot study.

Authors:  Fatma Al-Saeedi
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

Review 3.  Integration of progesterone receptor action with rapid signaling events in breast cancer models.

Authors:  Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-14       Impact factor: 4.292

Review 4.  Estrogen effects in the heart.

Authors:  T Pelzer; A Shamim; L Neyses
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

5.  Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation.

Authors:  P W Jurutka; J C Hsieh; S Nakajima; C A Haussler; G K Whitfield; M R Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Effect of post-synthetic modifications of proteins on the binding of estrogen-receptor complex to uterine nuclei of aging rats.

Authors:  J Kaur; M K Thakur
Journal:  Mol Biol Rep       Date:  1990-11       Impact factor: 2.316

7.  Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells.

Authors:  R J Miksicek; Y Lei; Y Wang
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Truncated forms of DNA-binding estrogen receptors in human breast cancer.

Authors:  G K Scott; P Kushner; J L Vigne; C C Benz
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 9.  Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

Authors:  S Christakos; M Raval-Pandya; R P Wernyj; W Yang
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

10.  Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists.

Authors:  D P Edwards; N L Weigel; S K Nordeen; C A Beck
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.